Medicxi
Est. dry powder
$578.2M
Raised, not yet invested
AUM
—
Not reported
Latest fund
$300M
Medicxi Growth I
Est. cheque size
$2.1M–
From fund sizes
Deals, last 12 months
4
Last seen investing Aug 2026
About Medicxi
Medicxi is a UK-based venture capital firm that focuses on investing in life sciences, biotechnology, therapeutics and biopharmaceuticals across the UK, the US and Europe.
- Type
- Venture Capital Firm
- Headquarters
- London, England, UK
- Stages
- SeedSeries ASeries BSeries CSeries DSeries EVenture DebtEarly Stage
- Est. cheque size
- $2.1M–$21.2M
- Sectors
- Healthcare, Diversified
- Regions
- Europe, North America
- Strategies
- Growth, Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series A21
- Series B13
- Series D5
- Series C3
- —1
Across 51 deals
Portfolio sectors
- Biotechnology28
- Pharmaceuticals8
- Biopolymers1
- Healthcare1
Across 38 companies
Portfolio countries
- US21
- UK10
- Netherlands3
- China1
- France1
Across 38 companies
Recent investments
Newest 5 of 51
- Series B$152M
Vaderis Therapeutics AG
Aug 2026 · Series B
- Series D$67.4M
Fore Biotherapeutics Inc.
Jul 2026 · Series D
- Series B$60M
Ethyreal Bio, Inc.
Jun 2026 · Series B
- Series B$108M
D3 Bio, Inc.
Dec 2025 · Series B
- Series D$38M
Fore Biotherapeutics Inc.
May 2025 · Series D
Offices
3 locations
- London, England, UKHQ
- Saint Helier, Jersey
- Geneva, Switzerland
Questions about Medicxi
How much does Medicxi invest per deal?
Based on the size of its funds, Medicxi writes estimated cheques of $2.1M–$21.2M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does Medicxi invest in?
Medicxi has invested at Seed, Series A, Series B, Series C, Series D and Series E. Its most frequent rounds on record are Series A, Series B and Series D.
How much capital does Medicxi have left to invest?
Medicxi has an estimated $578.2M in dry powder: capital it has raised but not yet invested.